↓ Skip to main content

Generic prescription drug price increases: which products will be affected by proposed anti-gouging legislation?

Overview of attention for article published in Journal of Pharmaceutical Policy and Practice, November 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#14 of 319)
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news
2 news outlets
blogs
1 blog
twitter
8 tweeters

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
30 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Generic prescription drug price increases: which products will be affected by proposed anti-gouging legislation?
Published in
Journal of Pharmaceutical Policy and Practice, November 2018
DOI 10.1186/s40545-018-0156-8
Pubmed ID
Authors

Rena M. Conti, Kevin H. Nguyen, Meredith B. Rosenthal

Twitter Demographics

The data shown below were collected from the profiles of 8 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 30 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 8 27%
Other 5 17%
Student > Doctoral Student 3 10%
Researcher 3 10%
Student > Ph. D. Student 2 7%
Other 1 3%
Unknown 8 27%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 4 13%
Social Sciences 4 13%
Nursing and Health Professions 4 13%
Economics, Econometrics and Finance 3 10%
Biochemistry, Genetics and Molecular Biology 1 3%
Other 3 10%
Unknown 11 37%

Attention Score in Context

This research output has an Altmetric Attention Score of 27. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 September 2020.
All research outputs
#979,616
of 18,990,581 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#14
of 319 outputs
Outputs of similar age
#32,840
of 408,131 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#3
of 31 outputs
Altmetric has tracked 18,990,581 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 319 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.4. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 408,131 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.